NCT03551236 is a clinical trial in Healthy Subjects, sponsored by Revenio Research.

Who is sponsoring NCT03551236?

NCT03551236 is sponsored by Revenio Research.

What condition does NCT03551236 study?

NCT03551236 studies Healthy Subjects.

Is NCT03551236 still recruiting?

NCT03551236 is currently completed. Last updated 11 June 2018.

Last reviewed 2018-06-11 · How we verify

NCT03551236

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Variability of Impedance Pneumography Tidal Breathing Flow-volume Curves During Sleep in Healthy Children

Completed Last updated 11 June 2018

What this trial tests

trial in Healthy Subjects in 40 participants. Completed in 3 July 2017.

Timeline

17 January 2017

Primary endpoint
3 July 2017

3 July 2017

Quick facts

Lead sponsor	Revenio Research
Status	Completed
Study type	OBSERVATIONAL
Enrollment	40
Start date	17 January 2017
Primary completion	3 July 2017
Estimated completion	3 July 2017
Sites	1 location across Croatia

Conditions studied

Healthy Subjects — all drugs for Healthy Subjects →

Sponsor

Revenio Research

Who can join

Eligibility, any sex, with Healthy Subjects. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This is an observational study for the assessment of normal overnight variation in small healthy children using the Ventica Lung Function Testing System. The study is carried out to establish reference ranges for overnight lung function variation using the Ventica test, and to assess the impact of the demographic factors on the Ventica results.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Expiratory variability index (EVI) is associated with the severity of acute bronchial obstruction in small children: A proof-of-concept study.
Seppä VP, Turkalj M, Hult A, Maloča Vuljanko I, et al · · 2020 · cited 7× · PMID 32307738 · DOI 10.1111/pai.13257

Verify or expand the search:

Other recruiting trials for Healthy Subjects

Currently open trials in the same condition.

NCT07222020 — Phase 1 Study of Intravaginal KB15A · Phase 1 · recruiting
NCT07350538 — The Critical Link Between Gut Microbiome Dysfunction, Cravings and Relapse: RECLAIM-GUT TRIAL · NA · active not recruiting
NCT07304791 — This is a Phase 1, Randomized, Single-blind, Placebo-controlled Study to Assess the Safety, Pharmacokinetics (PK), and P · Phase 1 · recruiting
NCT07059858 — Bladder and Bowel Functions, Participation and Quality of Life in Children With Intellectual Disabilities · recruiting
NCT07331389 — A Drug-Drug Interaction Study of HDM1002 and Metformin, Empagliflozin, Midazolam, Valsartan, and Warfarin · Phase 1 · recruiting

Other Revenio Research trials

Trials by the same sponsor.

NCT03488303 — Impedance Pneumography Measurement During Acute Airway Obstruction and Recovery Phase in Young Children · completed
NCT03408990 — Confounding Factors of Impedance Pneumography · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03551236 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Revenio Research
Last refreshed: 11 June 2018

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03551236.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing